reason report
bottom line reaffirm op rate pt
misunderstood beat one-tim item in-lin outlook
upsid acceler ambulatori growth like
immin conif sale progress hospit turnaround
conif sale appear late stage negoti particip
could yield sale spin-off merger combin maxim
sharehold valu initi outlook ebitda growth
line consensu time report believ upsid could
come acceler uspi growth faster hospit turnaround
exclud one-tim item malpractic risk-bas loss hurrican
gain sale adj ebitda would mm
consensu progress made hospit turnaround
opportun volum growth continu solid price
expect flow ambulatori segment remain solid
upsid could come ramp mm
solid organ growth save mm remain track
expect delev lower
ebitda mm mm respect reflect one-
time item pt base combin sotp
conif sale appear immin oper improv
drive sharehold valu manag highlight conif
sale late stage select buyer could yield
potenti sale spin-off merger combin sinc
bid process began conif outlook increas
mm drive addit valu potenti transact also
near final contract conif expect part
initi guidanc line upsid ambulatori acceler
acut volum rebound new detroit contract annual
servic line closur provid initi guidanc
ebitda growth midpoint mm compar consensu
mm time announc exhibit
revenu beat price ex-on timer ebitda also
beat exclud one-tim malpractic payment mm risk-bas
contract loss mm hurrican gain sale
minor interest mm adj ebitda would mm
consensu exhibit
ev/ebitda analysi sotp
net debt total capit
price-to-earnings lt ep growth
compani inform leerink partner llc research
revenu figur repres mm bad debt ep present ex one-tim item
pleas refer page import disclosur price chart analyst certif
guidanc lower reflect one-tim item
ebitda guidanc lower mm mm hospit declin
mm risk-bas loss ca mm malpractic one-tim increas
lower volum mix expect off-set mm gain
ambulatori segment conif ebitda unchang adj
ebitda midpoint guidanc mm versu consensu
mm time announc exhibit
hospit volum soft potenti rebound
new contract detroit medic center
sign septemb plan servic line closur
annual note market share non-divest
market market number number market posit
manag focus qualiti market initi drive
price solid net ca provid fee trend
expect continu focu invest higher
acuiti servic line shift lower acuiti patient inpati
er increas acuiti manag also highlight favor
rate good visibl contract solid
uspi ambulatori segment continu solid asset
could drive upsid ramp tuck-in ss
growth deploy mm ambulatori acquisit ytd
plan spend mm year-end pipelin remain activ
also engag jv partnership acut health
system ss surgic case growth solid qoq yoy
expect season strong ambulatori quarter exhibit
conif continu show oper improv margin
bp yoy revenu hospit divestitur
ebitda grow margin expect bp yoy
ebitda growth exhibit
expens manag remain track maintain
project run-rat cost save mm addit
save possibl plan expect yield mm
lower estim reflect one-tim
adjust lower ebitda mm
mm respect reflect one-tim item exhibit
continu expect greater valu unlock sotp basi
ambulatori segment ebitda expand
estim sotp part valuat net conif
hospit divestitur exhibit
hospit divestitur plan remain track possibl
addit divestitur though manag longer public
announc divestitur plan expect receiv proce
announc divestitur manag continu evalu
individu hospit addit divestitur possibl exhibit
progress made reduc leverag leverag
end achiev divestitur proce
view near-term matur lower
cffo guidanc maintain capital-expenditure guidanc
mm yoy
opportun leverag reduct exhibit
maintain op pt price target base
combin enterpris valu ebitda multipl valuat base
forward forecast contempl underli fundament
implic sum-of-the-part sotp valuat rang exhibit
reaffirm op rate pt misunderstood in-lin one-tim item in-
line outlook upsid acceler ambulatori growth like immin
conif sale progress hospit turnaround
conif sale appear late stage negoti particip could yield sale
spin-off merger combin maxim sharehold valu initi outlook
ebitda growth line consensu time report believ upsid could
come acceler uspi growth faster hospit turnaround exclud one-tim
item malpractic risk-bas loss hurrican gain sale adj ebitda would
mm consensu progress made hospit turnaround
opportun volum growth continu solid price expect flow
ambulatori segment remain solid upsid could come ramp
mm solid organ growth save mm remain track expect
delev
lower ebitda mm mm respect reflect
one-tim item pt base combin sotp ev/ebitda
conif sale appear immin oper improv drive sharehold valu
manag highlight conif sale late stage select buyer
could yield potenti sale spin-off merger combin sinc bid
process began conif outlook increas mm drive addit valu
potenti transact also near final contract conif expect
part potenti transact
last year made signific progress conif made number
chang within busi enabl us substanti improv perform
includ drive adjust ebitda growth year-to-d time
invest time energi explor potenti sale busi
viabl particip
realiz mani believ accomplish faster commit
sharehold right process deliber rais
opportun activ evalu conif could deliv valu
sharehold outright sale includ strateg altern merger
tax effici spin-off even combin altern transact
way take time improv conif perform
start today worth invest allow time
go wast need close process believ late stage
take time construct new contract tenet conif explor
detail option mention final decis right one conif
initi guidanc line upsid ambulatori acceler acut volum
rebound new detroit contract annual servic line closur
provid initi guidanc ebitda growth midpoint mm compar
consensu mm time announc
revenu beat price ex-on timer ebitda also beat exclud one-tim
malpractic payment mm risk-bas contract loss mm hurrican
gain sale minor interest mm adj ebitda would mm
guidanc lower reflect one-tim item ebitda guidanc
lower mm mm hospit declin mm risk-bas loss ca mm
malpractic one-tim increas lower volum mix expect off-set mm gain
ambulatori segment conif ebitda unchang adj ebitda midpoint
guidanc mm versu consensu mm time announc
mm except per share initi guidanceis guidanc guidanc guidanc guidanc lp estimate net incom cont op earn non-op divest net incom dilut tenet healthcar corpor
hospit volum soft potenti rebound new
contract detroit medic center sign septemb plan
servic line closur annual note market share non-divest
market market number number market posit manag focus
qualiti market initi drive volum growth
segment guidanceiniti guidancerevis guidanc guidanc guidanc guidanc lp estimate hospit othernet oper segmentnet oper segmentnet oper tenet healthcar corpor
price solid net ca provid fee trend expect continu
focu invest higher acuiti servic line shift lower acuiti patient
inpati er increas acuiti manag also highlight favor rate
good visibl contract solid medicar ff inpati rate
uspi ambulatori segment continu solid asset could drive upsid
ramp tuck-in ss growth deploy mm ambulatori
acquisit ytd plan spend year-end pipelin remain activ
also engag jv partnership acut health system ss surgic case
growth solid qoq yoy expect season strong
conif continu show oper improv margin bp yoy
revenu hospit divestitur ebitda grow margin expect
bp yoy ebitda growth
expens manag remain solid maintain project run-rat cost
save mm addit save possibl plan expect yield
mm save
lower estim reflect one-tim adjust lower
eebitda mm mm respect reflect one-tim item
driver termin fee revenuehospit volum growth exclud hurrican impact busi busi ebitda growth driven top line growth margin hurrican impactcost reduct mm mm cost save plan across hospit conif mm execut sever divestitur includ mm pend divestituresconif impact impact hospit divestitur wind health plandeclin ca risk base declin ca risk-bas contractsmalpractic time adjust malpractic hurrican impactca provid declin provid feemedicar medicar dsh acamedicaid tx fl ca provid fee annualizinghit hit leerink ebitda growth ramp mm ebitda growth bp margin expansioncost flow mm cost save planhospit organ hospit segment growth net volum headwind continu aspen hospit leerink tenet healthcar corpor
ebitda estim assum ebitda growth
continu expect greater valu unlock sotp basi ambulatori
segment ebitda expand estim sotp part valuat
net conif hospit divestitur
consensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net ni rev/adj admiss inpati admiss equiv admin corpor
ambulatori segment ebitda expand estim
sotp part valuat analysi assum conif divestitur addit
hospit divestitur current plan proce leverag
hospit divestitur plan remain track possibl addit divestitur
though manag longer public announc divestitur plan expect
receiv proce announc divestitur manag continu evalu
individu hospit addit divestitur possibl
progress made reduc leverag leverag end
achiev divestitur proce view near-
term matur lower cffo guidanc maintain capital-expenditure guidanc
mm yoy opportun leverag
leverag reduct come ebitda growth debt reduct
maintain op pt price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part sotp valuat rang
acut coverag trade ev/ebitda ebitda consensu
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
price target base pro forma ebitda leverag post transact
debt repay
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
delay time sale hospit asset initi improv physician
product expens reduct
exposur larg earn swing result high leverag
variou on-going legal proceed may result cash outflow
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut govern commerci payer reimburs
pressur shift outpati ambulatori set
pt line takeout price view acquisit like close
next month
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
margin expans headwind class
lack
risk privat equiti takeout merger close
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom statement mm except provis doubt net expensessalari oper total oper ebitda depreci invest ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut y-o-i chang share million dilut yoy dilut yoy growth expense/net opex/net debt/gross corpor
